Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...
Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement versus ...
Researchers have demonstrated in randomized controlled trial that compound lidocaine cream provides significantly better pain ...
NEW YORK - Oncolytics Biotech Inc. (NASDAQ:ONCY) announced alignment with the U.S. Food and Drug Administration on the design of a pivotal clinical study for pelareorep in patients with unresectable ...
Company to leverage strong durability and survival data in second-line and later metastatic squamous cell anal carcinomaPivotal study expected to ...
A data monitoring committee recommended stopping FLASH2, a randomized double-blind placebo-controlled confirmatory phase 3 ...
Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.
A consistent upward trend has been seen in extrapulmonary tuberculosis cases in the past five years, constituting nearly 24% ...
Architecture may hold the secret to slashing malaria rates in children by nearly half, researchers have found.
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...
Company to leverage strong durability and survival data in second-line and later metastatic squamous cell anal carcinoma Pivotal study expected to focus on patients in a post-standard-of-care patient ...
Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results